Results 41 to 50 of about 5,151 (200)
Darbepoetin alfa: An Effective Treatment with Flexible and Simplified Dosing for Anemia in Patients with Cancer [PDF]
, 2007 Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90361/1/phco.27.3.434 ...
Natale, James J., Stevenson, James G.
core +1 more source
Anemia correction by erythropoietin reduces BNP levels, hospitalization rate, and NYHA class in patients with cardio-renal anemia syndrome. [PDF]
, 2011 Little is known about the effect of anemia correction with erythropoietin (EPO) on B-type natriuretic peptide (BNP) levels, NYHA class, and hospitalization rate.
Antonelli, G +7 more
core +1 more source
Allergy, Asthma & Clinical Immunology, 2018 Background Recombinant human erythropoietin, such as epoetin alfa and darbepoetin alfa, is an important therapy for anemia due to chronic renal failure. Allergy to recombinant human erythropoietin and the need for desensitization are rare.
Jaime S. Rosa +3 more
doaj +1 more source
The role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions. [PDF]
, 2014 Anemia is a common finding in congestive heart failure (CHF) and is associated with an increased mortality and morbidity. Several conditions can cause depression of erythroid progenitor cells: reduction of iron absorption and reuptake, decreased bone ...
De Gori, C +6 more
core +1 more source
PSY34 Economic Evaluation of Ferinject in the Treatment of Anemia Patients in the Greek Hospital Setting: a Cost Minimization Analysis [PDF]
, 1880 Von ...
Fragoulakis, V. +4 more
core +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 848-858, April 2025.Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi +4 more
wiley +1 more source
Clinical Pharmacology &Therapeutics, Volume 119, Issue 2, Page 322-335, February 2026.Model‐informed drug development (MIDD) played a crucial role in the successful development and regulatory approval of daprodustat, a novel oral hypoxia‐inducible factor prolyl hydroxylase (HIF‐PHI) inhibitor aimed at treating anemia in chronic kidney disease patients.
Kelly M. Mahar +6 more
wiley +1 more source
Strategies for the Management of Postoperative Anemia in Elective Orthopedic Surgery [PDF]
, 2016 Objective: To assess the use of oral iron, intravenous (IV) iron, and erythropoiesis-stimulating agents (ESAs) for the prevention and management of perioperative anemia in elective orthopedic surgery patients, and to provide a clinical algorithm for use.
Howard, Meredith L. +2 more
core +2 more sources
Clinical and Translational Science, Volume 19, Issue 2, February 2026.ABSTRACT The Ministerial Ordinance on Good Post‐Marketing Study Practice for Drugs was amended by the Ministry of Health, Labour and Welfare (MHLW) in 2018 to clearly define post‐marketing database studies (DBS) as a measure of pharmacovigilance activities for approved medical products in Japan.
Suguru Okami +2 more
wiley +1 more source
Natural form of noncytolytic flexible human Fc as a long-acting carrier of agonistic ligand, erythropoietin. [PDF]
PLoS ONE, 2011 Human IgG1 Fc has been widely used as a bioconjugate, but exhibits shortcomings, such as antibody- and complement-mediated cytotoxicity as well as decreased bioactivity, when applied to agonistic proteins.
Se Jin Im +16 more
doaj +1 more source